ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

AIDS Biological Specimens Available From NIH

November 22, 1985

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979